Phenylsulfonylnitromethanes as potent irreversible inhibitors of aldose reductase

Author： Saab N.H.   Donkor I.O.   Rodriguez L.   Kador P.F.   Miller D.D.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.34, Iss.9, 1999-09, pp. : 745-751

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aldose Reductase Inhibitors from the Nature

By  

Current Medicinal Chemistry, Vol. 10, Iss. 15, 2003-08 ,pp. : 1353-1374

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Combined Pharmacophore Mapping and Quantitative Structure Selectivity Relationship Analysis for the Development of Potent and Selective Human Aldose Reductase Inhibitors

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 3, 2013-09 ,pp. : 371-384

Bentham Science Publishers

Access to resources Recommend Favorite

Aldose Reductase / Polyol Inhibitors for Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 373-385

Bentham Science Publishers

Access to resources Recommend Favorite

Development of aldose reductase inhibitors for the treatment of inflammatory disorders

By Chatzopoulou Maria   Pegklidou Kyriaki   Papastavrou Nikolaos   Demopoulos Vassilis J  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1365-1380

Informa Healthcare

Access to resources Recommend Favorite

Aldose reductase inhibitors: therapeutic implications for diabetic complications

By Oates P.J.   Mylari B.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2095-2119

Informa Healthcare

Access to resources Recommend Favorite